about
Fertility preservation in women with cervical, endometrial or ovarian cancersSurgical management of lung, liver and brain metastases from gynecological cancers: a literature reviewNew treatment option for ovarian cancer: PARP inhibitorsImmunotherapy in endometrial cancer - an evolving therapeutic paradigmFertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive successThe role of immune checkpoint inhibition in the treatment of ovarian cancerNew classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical careMechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy.Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001.Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways.Differentiating pelvic actinomycosis from advanced ovarian cancer: a report of two cases, management reflections and literature reviewDasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines.Updates on drug discovery in ovarian cancer.Uterine cervix metastasis from a sigmoid adenocarcinoma: a rare presentation of an uncommon tumor.Gynecologic Oncology Research and Practice: a new journal to meet the needs of a growing field.A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinib.Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience.Very late recurrence of Diethylstilbestrol - related clear cell carcinoma of the cervix: case report.Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy.Impact of cervical cancer on quality of life: beyond the short term (Results from a single institution): Quality of life in long-term cervical cancer survivors: results from a single institution.Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study.In vitro chemoresponse in metachronous pairs of gyneclologic cancersClinico-epidemiological profile of molar pregnancies in a tertiary care centre of Eastern Nepal: a retrospective review of medical recordsBreaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future.Diagnostic, therapeutic and evolutionary characteristics of cervical cancer in Department of Radiotherapy, Mohamed V Military Hospital - Rabat in Morocco.Willingness and acceptability of cervical cancer screening among women living with HIV/AIDS in Addis Ababa, Ethiopia: a cross sectional studyOpportunistic salpingectomy for ovarian cancer preventionLumbosacral plexopathy: A rare long term complication of concomitant chemo-radiation for cervical cancer.Long term follow-up of a phase II trial of multimodal therapy given in a "sandwich" method for stage III, IV, and recurrent endometrial cancer.Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies.Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysisGenetic testing in a gynaecological oncology care in developing countries-knowledge, attitudes and perception of Nepalese clinicians.Disparities in the surgical staging of high-grade endometrial cancer in the United States.Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review.Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report.Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature.Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial.Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?
P1433
Q26741087-3C1FFA32-50B6-43D9-BB8C-D6FFFF7F4FAFQ26743618-933FB3B5-2412-41B2-9DDE-DCDD6E9C0B5BQ26745614-5313C426-4293-44DF-965D-E744C4C67AD5Q27020910-C55C0943-53A6-4377-BED6-472C073A3A93Q28072802-E20C773F-0264-4415-B27F-43E821B9561FQ28077924-E4A685AF-18B7-433D-B8E0-FA1445E76F2FQ28078792-FF32883A-23F4-49B0-A287-77CE873CD733Q33755840-1CAB2D8C-280D-4ED0-BFFB-FE204E0E7D58Q33908553-E6618AD1-FFBC-437B-9602-E79B673D9017Q34528553-A9A7BD35-2FB7-4E42-8E54-8351C59D16B9Q36928958-EF284D58-A085-49BF-9B1A-FF2B70666B11Q36928987-9B674F15-2D4C-432E-8C2A-85C7E99390A9Q36929175-B92A346D-90B9-4406-A40B-500E06B78F43Q36929772-83D3ABA2-8747-43F9-A526-FDA7B651FCCCQ36929858-6B59ADE6-FCFE-4599-AB23-146A91762852Q36929898-A0A0C67D-9D56-4014-88AB-0339445B71A8Q36937081-60479005-E015-4069-9BB3-000657B749C8Q36937086-DCB7377B-C2F9-494E-9BB4-42522C03068AQ36937093-538000B6-1E36-4E47-93E9-0674FF37986AQ36937119-43011768-96F1-4C08-88D5-9957195AD52BQ36937216-3E96FFE1-5063-48EC-B49C-3C4BFA989392Q36937488-93AA0110-0FA5-4AEA-8916-83203D3ABED3Q36937532-960EE566-84DC-4E72-9D0B-F612DBE6AC41Q36937664-69314C2F-9081-400B-86E8-5F5BC425A5FFQ36937771-214D16BB-AD7C-494F-915E-8BF63D728505Q36937795-CD19AE2B-CCCD-468B-B579-573F278E2E74Q36938137-A1C37460-85E0-4EA4-97DE-10C34896577FQ36938143-8E514317-57EB-4983-98E5-B41DA1F1EBF6Q36938187-99BE56AE-7B73-4C01-972C-C5C4F2E8CA27Q37085242-D3B9CDBE-7A89-4391-9299-94E095EBAC00Q37364271-36F6F57D-1354-4DCB-BC06-F75BF1AC1C52Q37466261-2F192152-15B9-4527-BDFF-912897194C8BQ37472467-5C7CBFAE-8B10-44E9-B393-C13835B04451Q37595470-54EC0485-B0D3-4A98-88E8-1A78D3CE93E8Q37604996-1E850EDA-C698-406B-AA5A-6AAD7B37BF0DQ37622998-D5E01639-F2AF-466C-981D-D535D245B363Q37661436-5459FCF4-AC29-4FCC-928C-160EB764F9CCQ37679237-D417DAFB-DBBE-4111-BF75-A2C905257605Q37686466-944DE480-A203-4627-B82A-C64419F7C995Q37715530-8339D6A9-37E3-4B82-B810-290C90D542D1
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van BioMed Central
@nl
wissenschaftliche Fachzeitschrift
@de
name
Gynecologic oncology research and practice
@ast
Gynecologic oncology research and practice
@en
Gynecologic oncology research and practice
@es
Gynecologic oncology research and practice
@nl
type
label
Gynecologic oncology research and practice
@ast
Gynecologic oncology research and practice
@en
Gynecologic oncology research and practice
@es
Gynecologic oncology research and practice
@nl
altLabel
Gynecol Oncol Res Pract
@en
prefLabel
Gynecologic oncology research and practice
@ast
Gynecologic oncology research and practice
@en
Gynecologic oncology research and practice
@es
Gynecologic oncology research and practice
@nl
P3181
P1055
P123
P1277
P1476
Gynecologic oncology research and practice
@en